Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L

BMC Cell Biology

Volumn 13, Issue , 2012, Pages

  Birmpas, Charalampos ^a   Briand, Jean Paul ^b   Courty, Jose ^c   Katsoris, Panagiotis ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Angiogenesis; Cancer; HB 19; N6L; Nucleolin

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEOLIN; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; PSEUDOPEPTIDE; PSEUDOPEPTIDE N6L; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MIGRATION INHIBITION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INHIBITORS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; PEPTIDES; PHOSPHOPROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS;

EID: 84868647280     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-13-32     Document Type: Article

References (33)

1. Srivastava M, Pollard HB. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J 1999, 13:1911-1922.
2. Ginisty H, Sicard H, Roger B, Bouvet P. Structure and functions of nucleolin. J Cell Sci 1999, 112:761-772.
3. Storck S, Shukla M, Dimitrov S, Bouvet P. Functions of the histone chaperone nucleolin in diseases. Subcell Biochem 2007, 41:125-144. 10.1007/1-4020-5466-1_7, 17484127.
4. Semenkovich CF, Ostlund REJ, Olson MO, Yang JW. A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry 1990, 29:9708-9713. 10.1021/bi00493a028, 2176855.
5. Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 2003, 163:871-878. 10.1083/jcb.200304132, 2173679, 14638862.
6. Hovanessian AG, Soundaramourty C, El Khoury D, Nondier I, Svab J, Krust B. Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization. PLoS One 2010, 5:e15787. 10.1371/journal.pone.0015787, 3009748, 21203423.
7. Huang Y, Shi HHZ, Song X, Yuan S, Luo Y. The angiogenesis function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 2006, 107:3564-3571. 10.1182/blood-2005-07-2961, 16403913.
8. Tate A, Isotani S, Bradley MJ, Sikes RA, Davis R, Chung LW, Edlund M. Met-independent hepatocyte growth factor-mediated regulation of cell adhesion in human prostate cancer cells. BMC Cancer 2006, 6:197-212. 10.1186/1471-2407-6-197, 1559714, 16869958.
9. Said AE, Krust B, Nisole S, Briand JP, Hovanessian AG. The anti-HIV cytokine midkine binds the cell-surface-expressed nucleolin as a low affinity receptor. J Biol Chem 2002, 277:37492-37502. 10.1074/jbc.M201194200, 12147681.
10. Said EA, Courty J, Svab J, Delbé J, Krust B, Hovanessian AG. Pleiotrophin inhibits HIV infection by binding the cell surface expressed nucleolin. FEBS J 2005, 272:4646-4659. 10.1111/j.1742-4658.2005.04870.x, 16156786.
11. Di Segni A, Farin K, Pinkas-Kramarski R. Identification of nucleolin as new ErbB receptors- interacting protein. PLoS One 2008, 3:e2310. 10.1371/journal.pone.0002310, 2390759, 18523588.
12. Shi H, Huang Y, Zhou H, Song X, Yuan S, Fu Y, Luo Y. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 2007, 110:2899-2906. 10.1182/blood-2007-01-064428, 17615292.
13. Folkman J. Endostatin finds a new partner: nucleolin. Blood 2007, 110:2786-2787.
14. Turck N, Lefebvre O, Gross I, Gendry P, Kedinger M, Simon-Assmann P, Launay JF. Effect of laminin-1 on intestinal cell differentiation involves inhibition of nuclear nucleolin. J Cell Physiol 2006, 206:545-555. 10.1002/jcp.20501, 16245305.
15. Larrucea S, Gonza-lez-Rubio C, Cambronero R, Ballou B, Bonay P, Lopez-Granados E, Bouvet P, Fontán G, Fresno M, López-Trascasa M. Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement. J Biol Chem 1998, 273:31718-31725. 10.1074/jbc.273.48.31718, 9822633.
16. Harms G, Kraft R, Grelle G, Volz B, Dernedde J, Tauber R. Identification of nucleolin as a new L-selectin ligand. Biochem J 2001, 360:531-538. 10.1042/0264-6021:3600531, 1222254, 11736641.
17. Reyes-Reyes EM, Akiyama SK. Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells. Exp Cell Res 2008, 314:2212-2223. 10.1016/j.yexcr.2008.03.016, 2504360, 18504038.
18. Dumler I, Stepanova V, Jerke U, Mayboroda OA, Vogel F, Bouvet P, Tkachuk V, Haller H, Gulba DC. Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin. Curr Biol 1999, 9:1468-1476. 10.1016/S0960-9822(00)80116-5, 10607589.
19. Stepanova V, Lebedeva T, Kuo A, Yarovoi S, Tkachuk S, Zaitsev S, Bdeir K, Dumler I, Marks MS, Parfyonova Y, Tkachuk VA, Higazi AA, Cines DB. Nuclear translocation of urokinase-type plasminogen activator. Blood 2008, 112:100-110. 10.1182/blood-2007-07-104455, 2435680, 18337556.
20. Destouches D, Page N, Hamma-Kourbali Y, Machi V, Chaloin O, Frechault S, Birmpas C, Katsoris P, Beyrath J, Albanese P, Maurer M, Carpentier G, Strub JM, Van Dorsselaer A, Muller S, Bagnard D, Briand JP, Courty J. A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins. Cancer Res 2011, 71:3296-3305. 10.1158/0008-5472.CAN-10-3459, 21415166.
21. Haas TL. Endothelial cell regulation of matrix metalloproteinases. Can J Physiol Pharmacol 2005, 83:1-7. 10.1139/y04-120, 15759044.
22. Sluijter JP, de Kleijn DP, Pasterkamp G. Vascular remodeling and protease inhibition-bench to bedside. Cardiovasc Res 2006, 69:595-603. 10.1016/j.cardiores.2005.11.026, 16387286.
23. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006, 25:9-34. 10.1007/s10555-006-7886-9, 16680569.
24. Cross M, Dixelius J, Matsumoto T, Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem Sci 2003, 28:488-494. Review, 10.1016/S0968-0004(03)00193-2, 13678960.
25. Zhao X, Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev. 2011, 63:610-615. 10.1016/j.addr.2010.11.001, 3132829, 21118706.
26. Krust B, El Khoury D, Nondier I, Soundaramourty C, Hovanessian AG. Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type. BMC Cancer 2011, 11:333. 10.1186/1471-2407-11-333, 3199867, 21812966.
27. Destouches D, El Khoury D, Hamma-Kourbali Y, Krust B, Albanese P, Katsoris P, Guichard G, Briand JP, Courty J, Hovanessian AG. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. PLoS One 2008, 3:e2518. 10.1371/journal.pone.0002518, 2424174, 18560571.
28. El Khoury D, Destouches D, Lengagne R, Krust B, Hamma-Kourbali Y, Garcette M, Niro S, Kato M, Briand JP, Courty J, Hovanessian AG, Prévost-Blondel A. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. BMC Cancer 2012, 24:325.
29. Krust B, El Khoury D, Soundaramourty C, Nondier I, Hovanessian AG. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin. Biochimie 2011, 93:426-433. 10.1016/j.biochi.2010.10.015, 21040752.
30. Losfeld ME, Khoury DE, Mariot P, Carpentier M, Krust B, Briand JP, Mazurier J, Hovanessian AG, Legrand D. The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells. Exp Cell Res 2009, 315:357-369. 10.1016/j.yexcr.2008.10.039, 19026635.
31. Nisole S, Said EA, Mische C, Prevost MC, Krust B, Bouvet P, Bianco A, Briand JP, Hovanessian AG. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. J Biol Chem 2002, 277:20877-20886. 10.1074/jbc.M110024200, 11919179.
32. Nisole S, Krust B, Callebaut C, Guichard G, Muller S, Briand JP, Hovanessian AG. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. J Biol Chem 1999, 274:27875-27884. 10.1074/jbc.274.39.27875, 10488134.
33. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973, 52:2745-2756. 10.1172/JCI107470, 302542, 4355998.